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Cleidocranial dysplasia (CCD) is an autoso-
mal dominant, generalized skeletal dyspla-
sia in humans that has been mapped to the
short arm of chromosome 6. We report link-
age of a CCD mutation to 6p21 in a large
family and exclude the bone morphogenetic
protein 6 gene (BMP6) as a candidate for the
disease by cytogenetic localization and ge-
netic recombination. CCD was linked with a
maximal two-point LOD score of 7.22 with
marker D6S452 at u = 0. One relative with a
recombination between D6S451 and D6S459
and another individual with a recombina-
tion between D6S465 and CCD places the
mutation within a 7 cM region between
D6S451 and D6S465 at 6p21. A phage P1 ge-
nomic clone spanning most of the BMP6
gene hybridized to chromosome 6 in band
region p23–p24 using FISH analysis, placing
this gene cytogenetically more distal than
the region of linkage for CCD. We derived a
new polymorphic marker from this same P1
clone and found recombinations between
the marker and CCD in this family. The re-
sults confirm the map position of CCD on
6p21, further refine the CCD genetic inter-
val by identifying a recombination between
D6S451 and D6S459, and exclude BMP6 as a
candidate gene. Am. J. Med. Genet. 71:292–
297, 1997. © 1997 Wiley-Liss, Inc.
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INTRODUCTION
Cleidocranial dysplasia, CCD (MIM 119600), is an
autosomal dominant, generalized skeletal dysplasia in
humans characterized by short stature, delayed ossifi-
cation of the large fontanels and sutures of the skull,
wormian bones, midface hypoplasia, late eruption of
permanent teeth, malformed dental roots, enamel hy-
poplasia, supernumerary teeth, aplasia or hypoplasia
of the clavicles, other skeletal abnormalities, and nor-
mal intelligence [Gorlin et al., 1990 and references
therein; Spranger et al., 1974; Chitayat et al., 1992;
Jensen and Kreiborg, 1990]. The skull, clavicles, and
teeth exhibit the most apparent clinical abnormalities.
There is often a wide range of variability within a fam-
ily.
Brueton et al. [1992] described a mother and daugh-
ter and an unrelated individual with apparent CCD
associated with rearrangements involving 8q22. Nein-
haus et al. [1993] described a pericentric inversion in-
volving chromosome 6 in a patient with CCD. Recently,
four groups have localized the CCD gene using linkage
analysis to the proximal short arm of chromosome 6 in
several families [Feldman et al., 1995; Gelb et al., 1995;
Mundlos et al., 1995; Ramesar et al., 1996]. Even with
the localization of the CCD gene to chromosome 6p in
several families, genetic heterogeneity remains a pos-
sibility. The gene for bone morphogenetic protein-6
(BMP6) is a strong candidate for the CCD gene due to
its position on the short arm of chromosome 6 and its
expression pattern [Lyons et al., 1989; Hahn et al.,
1992].
We identified a large family segregating cleidocra-
nial dysplasia and sought to determine whether CCD
in this family is linked to 6p and, if so, whether the
BMP6 gene was located within the CCD genetic inter-
val.
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MATERIALS AND METHODS
DNA Preparation
DNA was prepared from whole blood using a Pure-
gene kit (Gentra Systems, Inc.). Thirty nanograms of
genomic DNA were used for amplification under stan-
dard reaction conditions and 28 cycles of PCR [Weber
et al., 1993].
Polymorphic Markers
All STR primer pairs, with the exception of D6S2257,
(shown in Table I) were obtained from Research Genet-
ics, Inc. For the new STR, D6S2257, derived from a
phage P1 genomic clone spanning most of the BMP6
gene, total P1 DNA was digested with Sau3AI, sub-
cloned into BamHI-cut, calf intestine alkaline phospha-
tase-treated phagemid vector pBluescript II KS+, and
individual colonies were screened with an alkaline
phosphatase-linked CA repeat probe (25–32 nucleo-
tides long) and visualized using a Quick-Light Genome
Mapping Probe kit (FMC Corp.). One positive clone
(GenBank accession number U63119) was sequenced
and found to have multiple complex dinucleotide re-
peat. The sequence of this new STR (D6S2257) was
PCR amplified with primers TF213: 58-AACTCCCAC-
ATCGTTCAAGG-38 and TF214: 58-GGGCCAGGAG-
TAAAGACACA-38. Allele sizes and frequencies for
D6S2257 were determined by PCR using DNA from 51
unrelated individuals. This marker amplified somatic
cell hybrid DNA (NIGMS Human/Rodent somatic cell
hybrid mapping panel 2, NA 10629) containing only
human chromosome 6 (data not shown). The same
preparation of P1 DNA allowed for amplification of
both D6S2257 and BMP6-specific PCR products. PCR
products were labelled during synthesis using a-33P-
dCTP and separated by electrophoresis on 6.5% dena-
turing polyacrylamide gels adjacent to sequencing lad-
ders and PCR products from CEPH DNA samples
whose allele sizes were known. Alleles were typed ac-
cording to fragment sizes independently by three in-
vestigators prior to linkage analysis. No parentage dis-
crepancies were identified in this family. With one ex-
ception, all STRs exhibited Mendelian segregation. For
the longest PCR products of D6S2257 allelic instability
was observed.
Linkage Analyses
Two-point linkage analyses were performed with IL-
INK and MLINK [Ott, 1991].
P1 Genomic Clone
A human P1 genomic clone library [Sternberg 1990,
1992] was screened with PCR primers derived from the
38 untranslated sequence of the published BMP6
cDNA [Celeste et al., 1990]. The primers were 58-
CAGTGCCTTATTACCCAGGAAG-3 8 and 5 8 -
TGGGAATGAACTGAACAGAGG-38, which amplify a
370 base pair product from human genomic DNA. One
P1 clone was isolated by a hierarchical, pooled screen-
ing strategy. This clone, P1-BMP6, was shown by PCR
and Southern blotting with BMP6 cDNA fragments to
harbor most of the BMP6 gene (data not shown). P1
clone DNA was purified with a Qiagen Plasmid Maxi
Kit.
FISH
FISH analysis was carried out using standard,
previously reported procedures [Wilke et al., 1996].
Metaphase chromosomes from a normal control were
prepared after PHA stimulation of whole blood lympho-
cytes and hybridized with a biotinylated (biotin-14-
dATP) probe prepared using the BioNick Labeling Sys-
tem (BRL, Gaithersburg, MD) from total P1-BMP6
clone DNA. Two hundred nanograms of biotinylated
probe and 10 mg of human Cot1 DNA (BRL, Gaithers-
burg, MD) were denatured at 75°C in 10 ml of 2×SSC,
10% dextran sulfate, 50% formamide, and 1% Tween
20, and preannealed at 37°C for at least 1 hour prior to
application to denatured slides. Slides were denatured
at 70°C for 2 minutes in 70% formamide, 2×SSC, pH
7.0, followed by a standard dehydrating ethanol wash
series. The hybridization of each slide was carried out
overnight in 10 ml 2×SSC (pH 7.0), 50% formamide,
10% dextran sulfate, and 1% Tween 20 at 37°C. Slides
were washed once in 50% formamide, 2×SSC at 42°C
followed by 0.1×SSC at 60°C. Signals were visualized
after incubations with FITC conjugated avidin-DCS
and biotinylated goat anti-avidin IgG (Vector Labs,
Burlingame, CA), followed by counterstaining with
propidium iodide alone or with both DAPI and prop-
idium iodide. The chromosomes were viewed with ei-
ther a Nikon or Zeiss Axioskop epifluorescence micro-
scope equipped with FITC and DAPI filters. Thirteen
separate normal chromosome spreads were photo-
graphed. Metaphase spreads prepared from CCD-
affected individual III-14 fibroblasts were hybridized
with the same probe and revealed two signals in each
cell examined (data not shown).
RESULTS
Twenty-one relatives spanning three generations of
a pedigree segregating CCD were examined by two of
us (J.W.I. and J.H.A.). All 13 affected relatives showed
characteristics of cleidocranial dysplasia (Fig. 1). Lym-
phocyte chromosome analysis showed no anomalies at
the 800 band level in an affected relative (III-12, data
not shown). DNA typing for markers on 8q showed no
linkage with CCD in this family (data not shown); how-
ever, several markers on chromosome 6p showed tight
linkage. The pedigree and haplotypes for linked mark-
ers are shown in Figure 1. The data are summarized in
Table I. CCD was linked to D6S451 with a LOD score
of 5.4 at u 4 0.038, D6S459 with a LOD score of 5.1 at
u 4 0, D6S452 with a LOD score of 7.22 at u 4 0, and
D6S438 with a LOD score of 4.8 at q 4 0. The CEPH
map indicates that the linkage order for these markers
is tel—D6S451-2cM-D6S459-4cM-D6S438-1cM-
D6S465—cen [Gyapay et al., 1994]. Two point LOD
score analysis with this family confirmed this marker
order (data not shown). One affected person (IV-10) in
this CCD family carries a chromosome with a recom-
bination between D6S451 and D6S459 and an unaf-
fected individual (II-3) carries a recombination be-
tween D6S465 and CCD. These recombinants allowed
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Fig. 1. Pedigree of family with haplotype data for markers on chromosome 6p from D6S451 to D6S465. Deduced haplotypes are shown for deceased
individuals except for III-11 for whom a DNA sample was obtained prior to death. Individual II-3 inherited a chromosome with a recombination between
D6S269 and D6S465. Individual IV-10 inherited a chromosome with a recombination between D6S451 and D6S459. Individual II-4 carries a new marker
variation at D6S438. The haplotype linked to the CCD gene is boxed.
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us to position the CCD mutation within a 7 cM region
between D6S451 and D6S465 (Fig. 2).
A potential candidate gene for CCD, BMP6, is known
to map to this general region of human chromosome 6
[Hahn et al., 1992; Volz et al., 1994]. BMP6 is known to
be expressed in a wide variety of organs including the
calvaria of the developing mouse [Lyons et al., 1989].
RT-PCR of fibroblast mRNA from individual III-14
showed no differences in the BMP6 mRNA sequence
corresponding to the mature protein of this TGFb-like
molecule (data not shown). We screened a human
phage P1 genomic library with primers derived from
the 38 untranslated sequence of the human BMP6 gene
and isolated a clone spanning part of the BMP6 locus.
This clone allowed for specific amplification of portions
of the BMP6 gene by PCR. A partial restriction map
was constructed by Southern blot analysis using non-
repetitive probes from the 38 half of the BMP6 cDNA
(data not shown). CCD-affected individual DNA
samples showed no rearrangements by Southern blot-
ting compared with normal controls (data not shown).
We used this P1 clone as a probe in FISH analysis on
metaphase chromosomes from a normal individual and
a CCD-affected family member. Normal hybridization
signals were observed using this clone on each meta-
phase examined; however, these signals were re-
stricted to the distal one third of the 6p arm, localizing
BMP6 to the 6p23-p24 band region (Fig. 3). Therefore,
even though BMP6 is located on 6p, it appears by FISH
to be too far distal to be a candidate for CCD since
markers shown to be nonrecombinant with CCD are
localized to chromosome 6p21.1-p21.2 [Feldman et al.,
1995; Gelb et al., 1995; Mundlos et al., 1995; Ramesar
et al., 1996; Volz et al., 1994].
In order to confirm the apparent separation of BMP6
from the CCD chromosomal region, we derived a poly-
morphic marker, D6S2257, from the P1 genomic clone,
and used this for molecular typing of the family. Using
51 unrelated individuals, this STS showed 13 different
alleles ranging in size from 171 to 201 base pairs with
85% heterozygosity and a PIC of 0.83 (Table II). Am-
plification was specific for the P1 clone DNA from
which the STS was derived and occurred only for so-
matic cell hybrids containing human chromosome 6
(data not shown). Instability in the size of the larger
PCR products of this STR was observed and is pre-
sumed to be the result of variability in the lengths of
several different repeated motifs within the STS. Those
meioses showing instability were excluded from the
linkage analysis. Multiple recombinants between CCD
and the new P1-BMP6 genomic clone marker were
identified in this family giving a LOD score of −2 at u 4
0.14. Therefore, by genetic marker analysis and by cy-
togenetic localization, BMP6 is excluded as a candidate
for CCD.
DISCUSSION
We have localized the human CCD gene to a 7 cM
region on 6p21 in agreement with other investigators
[Feldman et al., 1995; Gelb et al., 1995; Mundlos et al.,
1995; Ramesar et al., 1996]. The identification in our
study of a recombination between D6S451 and D6S459,
taken together with the data of Mundlos et al. showing
TABLE II. D6S2257 Allele Sizes and Frequencies














Fig. 2. Genetic map of the CCD locus and nearby markers on chromosome 6p. X symbols indicate the relative positions of meiotic recombinations
identified in the family. The bar denotes the position of the CCD locus defined by recombination breakpoints. The map integrates published genetic map
distances [Gyapay et al., 1994].
TABLE I. Pairwise Lod Scores (Z) at Different Recombination
Fractions (u) Between CCD and Chromosome 6 Markers





D6S291 −` −0.05 0.144 0.186 0.133 0.286 0.187
D6S451 −` 5.035 4.007 2.681 1.120 0.038 5.367
D6S459 5.117 4.202 3.179 2.028 0.777 0.000 5.117
D6S452 7.225 5.989 4.609 3.050 1.318 0.000 7.225
D6S438 4.816 3.947 2.976 1.886 0.719 0.000 4.816
D6S269 5.283 4.289 3.226 2.097 0.895 0.000 5.283
D6S465 −` 1.492 1.266 0.860 0.391 0.090 1.495
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a recombination distal to D6S438, indicates that CCD
is located in a region probably smaller than 6 cM be-
tween D6S451 and D6S438. For all markers tested, no
evidence of a microdeletion could be observed in the
family reported here. We have used FISH to localize
the BMP6 gene to chromosome band region 6p23-p24
and have identified several recombinations between
CCD and a marker near BMP6 in this family, thereby
excluding this gene from further consideration as a
candidate for CCD. Screening for mutations in this re-
gion must await the identification of genes within contigs
of genomic clones spanning the CCD genetic interval. Ad-
ditional families and more markers will help to narrow
the region in which to search for the CCD gene. Work
with the Ccd mutation in mice [Sillence et al., 1987] will
also facilitate the identification of the human CCD locus.
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